Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Spectrum (SPPI) and Ariad (ARIA) Pharma: Are You Paying Attention?

|Includes: ARIA, Spectrum Pharmaceuticals, Inc. (SPPI)
Spectrum Pharmaceuticals (NASDAQ:SPPI)

CMS - Check.

FDA meeting on Fusilev - TBA

Quarterly report scheduled for 1:00 PM ET next Friday, November 13, 2009.

Ariad Pharmaceuticals (ARIA)

The second interim look at Phase 3 data will be announced within Q1 2010.  It should also be noted that Merck (NYSE:MRK) is looking to make some acquisitions.  While Cramer likes Dendreon (NASDAQ:DNDN) and Onyx Pharma (NASDAQ:ONXX).  I like ARIA best.  MRK is collaborating with ARIA on ridaforolimus.  DNDN has a collab with Roche (OTCQX:RHHBY) via Genentech.  ONXX is collaborating with Bayer Schering (OTC:BYERF).  While I genuinely respect Cramer's opinion, his rationale does not make much sense to me.

Despite their volatility, I continue to like and own ARIA and SPPI.

Disclosure: Long ARIA and SPPI.